BACKGROUND
an intriguing interplay between cancer cells and the body's immune system has been reported, and includes both humoral and cellular pathways  <cit> . research into links between cancer and the immune system has aimed to acquire further understanding of the mechanisms involved  <cit> , but also addresses applications in diagnostics, disease surveillance, and therapeutic approaches  <cit> .

the antibody profile triggered in the course of tumor development  may be an immunologic fingerprint of the malignant tissue, in turn providing information on disease-associated proteins. experimental technologies for identification of such autoantigens include display methods such as phage display, serological expression cloning analysis , or protein arrays  <cit> . these approaches share the use of selected antigenic determinants to screen for autoantibodies in sera of cancer patients, so that clinically relevant tumor antigens may be indirectly detected. over the last decade an impressive number of autoantigens have been identified, and serex data have been made publicly accessible as a web database  <cit> . drawbacks of most display methods, as presently applied, include their limitation to linear epitopes and selection biases arising from various experimental procedures  <cit> . protein arrays might overcome both shortcomings, as structural epitopes are amenable to display, and, if processed correctly, may also take post-translational modification into account. only a limited number of proteins are presently available in arrays, however, and the arrays fail to attain significant and unbiased coverage even of the hitherto-annotated human proteome. furthermore, aberrant protein modification  may be an important source of antigens generating autoantibodies  <cit> , a fact not considered in most screening approaches.

to date, no conclusive explanation has been put forward for why certain proteins become autoantigens in the course of tumor development, whereas others do not. however, autoantibodies are frequently found to react with structures previously not displayed to the mature immune system, such as fetal or viral proteins expressed by malignant cells  <cit> . further examples include intracellular proteins released by cancer cells into the microenvironment, and the expression of abnormal splice variants  <cit> . antibodies targeted against mutant proteins are the most direct explanation for the stimulation of an immune response, and the antibodies may well exhibit cross-reactivities with native proteins. such data have been reported for the proteins encoded by p <dig>  and cdx <dig>  <cit> . it was also shown, however, that autoantibodies against p <dig> protein did not recognize the mutated part of the native protein  <cit> . interestingly, p <dig> mutations frequently cause increased stability of the protein, thereby increasing the relative concentration. this 'concentration effect' leads directly to another proposed cause of autoantigenicity, namely a high  abundance of a gene product in cancerous tissue  <cit> . thus, significant upregulation of a gene, followed by attainment of a high local concentration of the gene product, may trigger a humoral immune response against such a protein.

in the present study, we tested the hypothesis that the abundance of a protein in cancerous tissue is related to the probability that the protein will induce a humoral immune response. our analysis is based on data on differential gene expression in ovarian cancer  derived from a meta-analysis including publications comparing normal and cancerous tissue. a second major dataset is composed of public domain ovarian cancer autoantigens as derived by serex  <cit> . these two datasets represented the startpoint for study of the assumed interrelationship between differential gene expression and altered protein abundance on the one hand, and the occurrence of autoantibodies triggered by high abundance of proteins on the other. because of the excellent availability of both gene expression and serex data, ovarian cancer was chosen as a study case. a previous analysis of similarities of gene expression profiles in different tumors as stored in the cancer immunome database  <cit>  showed significant variability between tumors  <cit> , as did comparisons of serex datasets for different malignancies. we therefore focused our analysis on one particular tumor, namely ovarian cancer.

we have applied two procedures aimed at unraveling the postulated link between transcriptome and immunome. first, bioinformatics was utilized to compare transcriptional upregulation with experimentally verified autoantigenicity. the work included direct comparison of given gene or protein lists, and exploration of dataset interrelationships at the levels of transcriptional coregulation and protein-protein interaction networks. second, a selected group of differentially regulated proteins were explicitly tested for autoantigenic propensity in an experimental setting, following in silico antigenicity profiling and candidate epitope selection.

RESULTS
analysis workflow
datasets derived from a literature-based meta-analysis, as well as an experimentally derived list of autoantigens, formed the startpoint of analysis aimed at elucidating any relationship between differential gene expression and protein abundance on the one hand, and the propensity of such proteins to induce humoral immune responses on the other.

in a first analysis,  <dig> genes showing concerted upregulation in ovarian cancer, as identified by differential gene expression meta-analysis , were directly compared to the  <dig> public domain autoantigens identified by serex , thereby identifying three joint entries. these genes included the brca <dig> associated ring domain  <dig> , keratin  <dig> , and mesothelin . although this number of conjoint entries is computed as statistically significant  when compared to the number of conjoint members of randomly generated datasets, the number of direct overlaps of upregulated genes and autoantigens is, from a biological viewpoint, less than impressive. we identified only one entry in meta-down as an autoantigen, namely the platelet-derived growth factor receptor alpha polypeptide . the gene encoding pdgfra has been reported as mutated in cancerous tissue  <cit> , providing an explanation for the identified autoantigenic propensity independent of any differential abundance.

based on this direct comparison of meta-all and serex-ovarian datasets, no obvious link between upregulation in gene expression and a subsequent higher abundance of gene products with autoantigenic potential could be derived. however, both datasets most likely provide only a sample of the overall differential gene expression profile or the spectrum of autoantigens.

to overcome the shortcomings of such partial datasets, bioinformatics analysis was performed to bridge the gap between differential gene expression and assumed changes in protein abundance, and presumed autoantigenicity. concerted expansion of both datasets was undertaken. procedures used included transcriptional coregulation analysis, studies on conjoint pathways, and exploration of protein interaction networks. the goal of these procedures was to identify conjoint elements amongst transcription factors, pathways, or protein interaction networks, indirectly linking gene expression and autoantigenicity at the level of particular gene lists.

differentially expressed genes
the meta-up dataset contained  <dig> genes, ranked by reported literature frequency of differential expression. for example, the gene encoding mucin was reported as upregulated in seven publications, and as downregulated in one report. as listed in table  <dig>  some known cancer-associated autoantigens, including several not present in the serex-ovarian dataset, were included in the meta-up list , of which the most prominent was mucin  <dig>   <cit> . the tumor-associated calcium signal transducer  <dig>   <cit> , mesothelin   <cit> , heat shock protein  <dig>   <cit> , keratin  <dig>   <cit>  and brca1-associated ring domain  <dig>   <cit>  are included.

interestingly, muc <dig> and tacstd <dig> were ranked among the top upregulated genes, thus supporting a link between enriched protein concentration and likelihood of autoantigenicity. this finding was further supported by our failure to find known autoantigens in the list of downregulated genes, meta-down.

transcriptional coregulation
scanning the upstream regions of genes in the meta-up dataset resulted in the identification of  <dig> transcription factors  with significantly enriched numbers of binding sites when compared to the distribution of transcription factor binding sites found in randomly picked sequences . among the most significant tfs were those encoded by e2f, hif <dig>  nfy or ets <dig>  all previously reported to activate a number of genes overexpressed in various cancers  <cit> . in the serex-ovarian dataset, six tfs were detected with enriched binding site numbers, namely those encoded by gata <dig>  myod, nfkb, ik <dig>  hif <dig> and arnt. gata <dig> features in the growth and maturation of a diverse set of tissues. myod is important in muscle differentiation, and may be involved in inhibition of cell proliferation. nfkb is a well-known regulator of cell growth. more interestingly, hif <dig> is a master regulator coordinating oxygen homeostasis, and allows the cell to survive a lack of oxygen, a relevant situation in malignant tissue.

genes listed in meta-up share significantly more transcription factors than do genes in the serex-ovarian dataset. the ovarian cancer gene list derived by our literature meta-analysis thus appears to be under more stringent control than the serex-ovarian gene set, exerted by a defined set of transcription factors.

the number of shared motifs in the serex-ovarian dataset is lower than that in the meta-up collection, although comparable numbers of sequences were analyzed . joint regulatory control seems more evident in the gene expression dataset and less pronounced in the list given by serex-ovarian. amongst the six tfs enriched in the serex-ovarian dataset, however, four, namely gata <dig>  myod, ik <dig> and hif <dig>  were also found in the meta-up dataset, indicating a weak link between the datasets with respect to transcriptional regulation.

conjoint pathway analysis
for the approximately  <dig>  genes stored in the refseq nonredundant sequence database, about  <dig>  distinct assignments of gene identifiers and respective pathways are currently defined in the kegg  database  <cit> . for the meta-up gene dataset we found  <dig> distinct pathways, and for the serex-ovarian gene dataset  <dig> such pathways, where each pathway held at least one gene from the given gene lists.

of this total of  <dig> pathways,  <dig> conjoint elements  were found. these were cell communication, cytokine-cytokine receptor interaction, tgf-beta signaling, focal adhesion, ecm receptor interaction, adherence junctions, tight junctions, leukocyte transendothelial migration, and regulation of the actin cytoskeleton. to determine the statistical significance of this finding, we utilized a dataset generation procedure to derive  <dig>  random gene lists holding the same number of entries . for each of the randomly composed datasets, the numbers of conjoint pathways were computed. this procedure resulted in a normal distribution of conjoint pathways, showing a mean of  <dig>  pathways jointly held by two randomly generated datasets, compared to the nine conjoint pathways populated by meta-up and serex-ovarian genes. therefore, no significant enrichment of conjoint pathways between meta-up and serex-ovarian datasets was noted.

protein-protein interactions and networks
we expanded the lists of genes encoded by the datasets using nearest neighbor expansion based on ophid protein-protein interaction data  <cit> . this approach is based on the rationale that proteins showing differential abundance might show interactions with other proteins embedded in the same functional context . the resulting interaction networks, as well as their aggregation indices  <cit>  with respect to a reference curve based on random gene selections, are shown in figure  <dig> 

for meta-up, the procedure resulted in networks consisting of  <dig> nodes and  <dig> edges. the largest subnetwork was composed of  <dig> nodes and  <dig> edges. thirty of the  <dig> detected genes stored in the meta-up dataset were found in the largest subnetwork, resulting in an index of aggregation  of  <dig> . corresponding ias for the meta-down, meta-all, and serex-ovarian datasets were  <dig> ,  <dig> , and  <dig> , respectively.

to permit statistical evaluation of these aggregation indices, a reference curve holding mean ias and standard deviations for  <dig>  randomly generated datasets containing 5â€“ <dig> genes was computed. this procedure is based on the following rationale: datasets derived by a systematic selection procedure  may be characterized by aggregation indices clearly exceeding the ias of randomly generated datasets if they show ias at least one standard deviation above the mean ia of reference datasets with equal numbers of elements. we additionally constructed an interaction network based on genes stored in meta-up including  enriched transcription factors. the resulting network showed an ia of  <dig> , and this was highly significant when compared to the distribution obtained from random datasets. despite putative biases in this dataset generation procedure , all datasets exhibited internal structures on the level of protein-protein interaction networks. however, datasets derived by differential gene expression clearly showed higher protein-protein interaction network complexity than did the serex-ovarian dataset.

direct comparison of gene identifiers in the meta-up and serex-ovarian datasets resulted in three joint entries, as noted above. the number of genes shared between the datasets after performing nearest neighbor expansion at the level of protein-protein interactions is presented in table  <dig> 

as clearly indicated by respective pairwise comparisons of original datasets and expanded datasets, the overlap between gene expression and serex-ovarian datasets is still minor. the meta-up dataset including associated transcription factors and nearest neighbors at the level of protein-protein interaction resulted in a list of  <dig> proteins of which, in addition to the three entries already identified via direct comparison, only three additional entries  were also listed in the serex-ovarian dataset.

information derived by comparison of gene expression and serex-ovarian datasets, although expanded by coregulation and network analysis, indicated no major link between local abundance of a protein and its potential for autoantigenicity, at least at the level of given datasets. differential gene expression appears to affect functional dependencies identified on the basis of transcription factors involved in regulation, and protein interaction partners, whereas particular autoantigens appear to be random selections from the human proteome.

to ascertain if the given datasets were biased selections, therefore failing to provide significant overlaps, or if abundance  might not be linked to increased propensity for autoantigenicity at all, explicit experimental testing was performed.

immunogenicity profiling
to finally test whether upregulation might increase the autoantigenic potential of a protein , in silico immunogenicity screening of proteins encoded by upregulated genes was performed. identified candidate epitopes were subsequently tested experimentally for identification of reactive antibodies in ovarian cancer patient sera.

we included all sequences from the meta-up dataset which were reported as upregulated in at least three publications . we further included three sequences listed in meta-up which were also reported in the serex-ovarian dataset. further, the top five upregulated genes of the two gene expression raw datasets at hand were selected  <cit> , as was tp <dig>  a well-known cancer autoantigen  <cit> , serving as a positive control.

in total,  <dig> proteins were identified for virtual immunogenicity profiling by our selection procedure. we utilized e-score to identify candidate linear epitopes on the proteins. e-score uses the primary sequence of a protein and combines structural features via 2d/3d structure prediction and solvent accessibility analysis with a neural network-based immunogenicity scoring function. the outputs of the scoring procedure are linear candidate b-cell epitopes . thirty-one of the  <dig> proteins gave promising immunogenicity profiles; the remaining  <dig> proteins were not analyzed further. from the  <dig> proteins providing good immunogenicity profiles,  <dig> individual candidate epitopes were selected, synthesized, and experimentally used. as a reference dataset,  <dig> candidate epitopes from  <dig> proteins randomly picked from the meta-down dataset were selected.

experimental epitope verification
the peptides were screened in a peptide-elisa setting, mounting biotinylated candidate epitopes on streptavidin-coated microtiter plates. peptides were then screened utilizing sera from ovarian cancer patients and sera from healthy controls to determine the prevalence of antibodies which showed reactivities with the peptides. all  <dig> peptides of each dataset were screened using a tumor sera pool  obtained from ovarian cancer patients and a reference sera pool  from non-cancer female patients. table  <dig> lists the clinical characteristics of patients whose sera were used.

elisa signal intensities were compared between the sample groups using student's t-test, and a significant difference was found when reactivities of healthy and diseased sera on epitopes derived from upregulated genes were compared . in contrast, no significant difference was observed between tumor and reference sera pools reacting with epitopes derived from meta-down proteins. when all candidate epitopes were included in the statistical analysis, however, the absolute difference between reference and tumor sera was small also for meta-up candidate epitopes. first, it is likely that not all upregulated genes provide proteins triggering autoantibody production because of various host factors. second, the in silico epitope prediction may have missed important immunogenic determinants. figure 3a shows sera reactivity of tumor and reference sera for the  <dig> of the  <dig> proteins showing the largest reactivity differences; figure 3b provides the data for the remaining  <dig> proteins.

among the upregulated and most-reactive proteins, four well known autoantigens reported in various tumors were found, namely msln , bard <dig> , lnx  and tp <dig> , which we included as an internal control. interestingly, a series of receptor molecules was identified as potential autoantigenic components in ovarian cancer. these included the folate receptor , the protein tyrosine phosphatase receptor type f , the g protein-coupled receptor  <dig> , atpase subunit b <dig> , and the tumor-associated calcium signal transducer  <dig> . in particular, the identification of tacstd <dig> is interesting. this protein belongs to a family including at least two type i membrane proteins, one of which is the widely investigated tacstd <dig>  better known as epithelial cell adhesion molecule . autoantibodies in the sera of tumor patients, in particular those with ovarian cancer, have been reported for ep-cam  <cit> .

it is important to note that the screening results given in figures  <dig> and  <dig> are based on data indicating upregulation at the level of differential gene expression, not necessarily correlating with changes in protein abundance. we therefore scanned both the literature and the human protein atlas  <cit>  for indications of increased protein abundance of the sequences included in figure 3a and figure  <dig>  for  <dig>  of the  <dig> proteins, clear evidence for increased protein concentrations in ovarian cancer tissue compared to normal ovarian epithelium is available  <cit> , supporting the link between upregulation at the gene expression level and increased protein abundance.

CONCLUSIONS
in our work, ovarian cancer was used as a test system to investigate whether high expression of cancer-associated proteins is linked to an increased propensity towards autoantigenicity in the context of a humoral immune response. the startpoint of our analysis was the integration of datasets derived from public domain differential gene expression analyses, as well as reported serex data on ovarian cancer autoantigens.

the meta-analysis of  <dig> publications showed differential gene expression of more than  <dig>  genes. only  <dig> genes, however, were reported in more than one publication, clearly reflecting shortcomings in experimental procedures and downstream processing of differential gene expression analyses, as well as the heterogeneous nature of this tumor entity  <cit> . amongst the  <dig> genes,  <dig> were reported as upregulated  and  <dig> as downregulated .

in a first step, we explicitly compared our literature-derived meta-up gene set with the serex-defined autoantigens for ovarian cancer . three conjoint genes were identified, whereas only one protein represented in meta-down  was also present in the serex-ovarian dataset. additionally, a set of literature-reported cancer autoantigens was found in meta-up but not in meta-down, including mucin  <dig> , the tumor associated calcium signal transducer  <dig> , and the heat-shock protein  <dig>   <cit> . these examples indicated a link between gene overexpression and protein autoantigenic potential, whereas a direct comparison between gene expression data and serex-ovarian genes did not suggest such a correlation.

presentation to the humoral immune system is mandatory for triggering the production of antibodies, a process facilitated either by antigen presenting cells, or occurring via direct antigen access. consequently, autoantigens may accumulate in the extracellular space or cell wall, or may be secreted. however, serex-defined gene products show a tendency towards nuclear location. one explanation for this finding might be cell breakage and consequent necrosis in the course of tumor progression.

in any case, both datasets most likely represented but small selections of differentially expressed genes or autoantigens. in light of this, transcriptional coregulation analysis, pathway analysis, and protein-protein interaction analysis were performed to identify indirect links between the given datasets. on the level of transcriptional coregulation, we identified a series of well-known, cancer-associated tfs as over-represented in meta-up, significantly overlapping with enriched tfs also found in the common cancer profile dataset of rhodes et al. . a smaller number of tfs characteristic of the serex-ovarian dataset was identified, but, amongst the six tfs found, four were also characteristic of the meta-up gene set.

after protein-protein interaction analysis, interaction networks derived from both the serex-ovarian and meta-up datasets showed increased ias; however, even after a first neighbor expansion, the overlap between the datasets did not increase significantly. the protein-protein interaction analysis revealed a systematic logic in and inherent complexities of both the meta-up and serex-ovarian datasets. however, the datasets could not be convincingly linked via one-neighbor extension. weak correlation was also found when searching for conjoint kegg pathways  <cit> . nine of  <dig> pathways were identified as jointly populated by entries from the meta-up and serex-ovarian datasets.

based on these results, a tight linkage between high abundance as identified by differential gene expression analysis, and autoantigenic potential as found by membership of the serex-ovarian dataset, could not be shown. the gene expression dataset on its own appears conclusive, exhibiting a significant number of joint transcription factors, good integration with kegg pathways, and a high ia at the level of protein-protein interactions. the serex-ovarian dataset showed a less integrated picture, but is clearly set apart from randomly selected gene lists. the true set of autoantigens might therefore still be linked to concerted intracellular events, not necessarily coupled to massive changes in expression, in contrast to a profile appearing as random, as would result if cell breakage and necrosis were the sole sources triggering a humoral response against intracellular proteins.

to further study potential links between protein overexpression and autoantigenicity, we explicitly tested  <dig> proteins showing strong upregulation in an experimental setting. after identifying candidate epitopes on these proteins with an in silico prediction procedure, we conducted elisa screenings using sera from ovarian cancer patients and from healthy subjects. although reactivities varied notably amongst different patient sera, we successfully identified  <dig> epitopes on  <dig> proteins. proteins were ranked with respect to sera reactivities. the well-described autoantigen tp <dig> was found amongst the top-ranked proteins, supporting the validity of our approach. even higher serum reactivity than found for tp <dig> was observed for six proteins, namely msln, bard <dig>  pxdn, folr <dig>  ddx <dig> and ube2c. proteins msln and bard <dig> are well-known autoantigens of ovarian cancer and have also been found by serex. protein pxdn is a melanoma-associated protein and the ubiquitin-conjugating enzyme e2c  is believed to play a role in tumor progression  <cit> . folate receptor  <dig> has often been reported as significantly upregulated in ovarian cancer and is also known as ovarian carcinoma-associated antigen  <cit> . to date, no link to cancer or to a humoral autoimmune response has been reported for the rna helicase ddx <dig>  indicating that this is a newly-described autoantigen. in contrast to results obtained by comparing the meta-up and serex-ovarian datasets, our experimental data point towards a link between protein overexpression and autoantigenicity. following an integrated analysis approach, diverse links between the various layers of differential gene expression, transcriptional coregulation, protein-protein interactions, and autoantigenicity, can be drawn, as schematically represented in figure  <dig> 

